Mediterranean diet study for Parkinson's disease
Part of Brain & nervous system clinical trials.
This trial tests whether a Mediterranean diet can help people with Parkinson's disease. You would either follow your usual diet or switch to a Mediterranean diet for six months and provide blood and stool samples.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Diagnosed with Parkinson's disease
- Age 40 to 85 years
- Not taking medication or on a stable dose for at least 2 weeks
- Disease severity at Hoehn & Yahr stage 3 or less (able to walk and live independently)
- Able to eat on your own without help
- Willing to provide blood and stool samples after fasting for 12 hours
- Willing to stop supplements, probiotics, and high-dose vitamins during the study
- No other health issues that would make participation difficult
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an online Mediterranean diet program for people with Parkinson's disease. The goal is to see if it can improve health and quality of life by encouraging a diet rich in fruits, vegetables, whole grains, and healthy fats.
This study looks at how diet and the bacteria in your gut (microbiome) affect Parkinson's symptoms. You'll work with a coach and take cooking classes to see if changing what you eat can help you feel better.
This study tests whether a Mediterranean diet can improve nutrition in people with Parkinson's disease who have had deep brain stimulation surgery. It may help you maintain better nutrition and overall health.
This study looks at how changing your diet might affect the connection between your gut, immune system, and brain in Parkinson's disease. If you qualify, you would likely follow a specific diet for a period to see if it helps with symptoms.
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
This study looks at how certain gut bacteria (methanogens) are involved in the progression of Parkinson's disease and related conditions. It aims to understand the connection between gut health and brain health, which may lead to better treatments.
Hear when a new Parkinson trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.